DE69110740D1 - Im Dickdarm zerfallende, Polypeptide enthaltende orale Formulierungen. - Google Patents

Im Dickdarm zerfallende, Polypeptide enthaltende orale Formulierungen.

Info

Publication number
DE69110740D1
DE69110740D1 DE69110740T DE69110740T DE69110740D1 DE 69110740 D1 DE69110740 D1 DE 69110740D1 DE 69110740 T DE69110740 T DE 69110740T DE 69110740 T DE69110740 T DE 69110740T DE 69110740 D1 DE69110740 D1 DE 69110740D1
Authority
DE
Germany
Prior art keywords
disintegrating
oral formulations
containing polypeptides
chitosan
physiologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69110740T
Other languages
English (en)
Other versions
DE69110740T2 (de
Inventor
Takeru Fujii
Shigeyuki Takama
Takahiko Watoh
Tsutomu Suzuki
Takayuki Matsumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aicello Chemical Co Ltd
Original Assignee
Aicello Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicello Chemical Co Ltd filed Critical Aicello Chemical Co Ltd
Application granted granted Critical
Publication of DE69110740D1 publication Critical patent/DE69110740D1/de
Publication of DE69110740T2 publication Critical patent/DE69110740T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69110740T 1990-04-23 1991-04-22 Im Dickdarm zerfallende, Polypeptide enthaltende orale Formulierungen. Expired - Fee Related DE69110740T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP02107060 1990-04-23
JP3100304A JPH0813748B2 (ja) 1990-04-23 1991-04-05 大腸崩壊性ポリペプチド系経口製剤

Publications (2)

Publication Number Publication Date
DE69110740D1 true DE69110740D1 (de) 1995-08-03
DE69110740T2 DE69110740T2 (de) 1995-11-23

Family

ID=26441356

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69110740T Expired - Fee Related DE69110740T2 (de) 1990-04-23 1991-04-22 Im Dickdarm zerfallende, Polypeptide enthaltende orale Formulierungen.

Country Status (8)

Country Link
EP (1) EP0454383B1 (de)
JP (1) JPH0813748B2 (de)
KR (1) KR100262202B1 (de)
AT (1) ATE124255T1 (de)
CA (1) CA2041044C (de)
DE (1) DE69110740T2 (de)
DK (1) DK0454383T3 (de)
ES (1) ES2075348T3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH064531B2 (ja) * 1990-06-04 1994-01-19 アイセロ化学株式会社 大腸崩壊性硬質カプセル
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
DK0667148T3 (da) * 1992-11-06 2002-07-22 Hisamitsu Pharmaceutical Co Peroralt farmaceutisk præparat, der udløses i den nedre del af mavetarmkanalen
CN1072964C (zh) * 1994-04-22 2001-10-17 山之内制药株式会社 结肠特异性释药系统
JPH10513202A (ja) * 1996-06-11 1998-12-15 ゾナジェン,インコーポレイテッド キトサン薬物送達システム
US6248362B1 (en) * 1997-03-26 2001-06-19 Meiji Seika Kaisha, Ltd. Large intestinal delivery composite
FI20000780A (fi) * 2000-04-03 2001-10-04 Novasso Oy Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
PT1615646E (pt) 2003-04-08 2015-02-12 Progenics Pharm Inc Formulações farmacêuticas com metilnaltrexona
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
MX351611B (es) 2007-03-29 2017-10-20 Wyeth Llc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
ES2570374T3 (es) 2007-03-29 2016-05-18 Progenics Pharm Inc Antagonistas del receptor opioide periférico y usos de los mismos
WO2009099411A1 (en) 2008-02-06 2009-08-13 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
WO2010062261A1 (en) * 2008-11-29 2010-06-03 The Thailand Research Fund System and method for preparing a controlled releas preparation
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
CN102552919B (zh) * 2010-12-15 2018-03-27 上海安博生物医药股份有限公司 一种给药组合物及其制备和使用方法
WO2011084618A2 (en) * 2009-12-16 2011-07-14 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
JP5102401B1 (ja) 2012-03-30 2012-12-19 森下仁丹株式会社 大腸特異崩壊性カプセル
ITUA20161937A1 (it) * 2016-03-23 2017-09-23 S I I T S R L Servizio Int Imballaggi Termosaldanti Preparazione per il controllo del peso corporeo a base di chitosano e cellulosa
CN115192537B (zh) * 2022-07-27 2024-03-26 康普药业股份有限公司 一种甲磺酸萘莫司他组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001034A1 (en) * 1987-07-24 1989-02-09 The Regents Of The University Of Michigan Encapsulation of biological materials in semi-permeable membranes

Also Published As

Publication number Publication date
JPH0813748B2 (ja) 1996-02-14
DK0454383T3 (da) 1995-11-13
DE69110740T2 (de) 1995-11-23
EP0454383B1 (de) 1995-06-28
CA2041044C (en) 1996-03-26
KR920005690A (ko) 1992-04-03
KR100262202B1 (ko) 2000-09-01
JPH04225922A (ja) 1992-08-14
EP0454383A1 (de) 1991-10-30
CA2041044A1 (en) 1991-10-24
ATE124255T1 (de) 1995-07-15
ES2075348T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
DE69110740D1 (de) Im Dickdarm zerfallende, Polypeptide enthaltende orale Formulierungen.
DE69226950D1 (de) Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt
DE69109557T2 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
DE69803940T2 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
DE69109284T2 (de) Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe.
ES2075468T3 (es) Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.
AU7992987A (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch
CA2046830A1 (en) Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
DE68915291D1 (de) Verschlusskörpr zur verabreichung einer physiologisch aktiven substanz.
NO910687L (no) Fremgangsmaate for fremstilling av et stabilt soetningsmiddel-utleveringssystem og tyggegummi.
BE874596A (fr) Medicament sous la forme d'une solution aqueuse sterile stable de cisplatine
NO168040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater.
FR2662160B1 (fr) Derives d'alkylthio-3 propyl-3 benzothiazoline leur preparation et les medicaments les contenant.
EP0269452A3 (de) Anwendung von Keton-Derivaten zur Herstellung von Arzneimitteln
NO893768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
ITMI922018A0 (it) Bassi polimeri dell'n-vinilpirrolidone monofunzionalizzati ad un estremo per la preparazione di coniugati con enzimi, polipeptidi farmaci
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.
FR2661910B1 (fr) Derives d'imino-2 heterocyclylalkyl-3 benzothiazoline, leur preparation et les medicaments les contenant.
IS4288A (is) 2,4-dísúlfónýlfenýlbútýlnítrón, sölt þess, lyfjablanda ásamt notkun á þessu efnasambandi við framleiðslu á lyfi
IT1216089B (it) L'igiene degli arti inferiori. stivaletto ad azione idro massaggiante, per la cura e
TH9752EX (th) อ่างอาบน้ำ
TH5715EX (th) ผ้าอนามัย
DE3780893D1 (de) Formulierung zur herstellung von arzneimitteln mit verzoegerter freisetzung zur oralen gabe.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee